Drug profile

The FDA adverse-event record for Omega-3 And Omega-6 Fatty Acids

15 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Omega-3 And Omega-6 Fatty Acids. See the species affected, top reactions, and outcomes below.

15
adverse-event reports
0.0%
death-coded share
Dog
most-reported species
6
Emesis - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
15
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Omega-3 And Omega-6 Fatty Acids

Administration Routes

OralUnknown

Species Affected

Dog 15

Most Affected Breeds

Shepherd Dog - Australian 2
Retriever - Labrador 2
Shih Tzu 2
Dalmatian 1
Bulldog 1
Spaniel (unspecified) 1
Terrier - West Highland White 1
Retriever - Golden 1
Terrier (unspecified) 1
Crossbred Canine/dog 1

Most Reported Reactions

Emesis 6
Lethargy (see also Central nervous system depression in 'Neurological') 2
Lack of efficacy - NOS 2
Vomiting 1
Decreased appetite 1
Emesis (multiple) 1
Hives (see also 'Skin') 1
Diarrhoea 1
Pruritus 1
Behavioural disorder NOS 1
Reduced responses 1
Limping 1

Outcome Breakdown

Recovered/Normal
11 (73.3%)
Outcome Unknown
2 (13.3%)
Recovered with Sequela
2 (13.3%)

Omega-3 And Omega-6 Fatty Acids Adverse Event Insights

15 reports name Omega-3 And Omega-6 Fatty Acids; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Omega-3 And Omega-6 Fatty Acids. Administration routes: Oral, Unknown.

By species: Dog (15 reports). By breed: Shepherd Dog - Australian (2), Retriever - Labrador (2), Shih Tzu (2).

Leading clinical signs: Emesis (6), Lethargy (see also Central nervous system depression in 'Neurological') (2), Lack of efficacy - NOS (2), Vomiting (1). Outcome, 15 coded reports: Recovered/Normal leads at 73.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.